General - Press Releases

Date	Title	Company
03-Oct-2023	Kashiv BioSciences Enters into Exclusive Licensing Agreement with Alvotech for Development & Commercialization of a Proposed Biosimilar to Xolair® (omalizumab)	Businesswire
03-Oct-2023	$18.5 Billion Sleep Apnea Diagnostic System Markets - Global Size, Share, Outlook, and Opportunity Analysis, 2023-2030 with 2022 as the Base Year - ResearchAndMarkets.com	Businesswire
03-Oct-2023	MAIA Biotechnology Announces FDA Clearance of IND Application for THIO, a First-in-Class Telomere Targeting Agent for the Treatment of Non-Small Cell Lung Cancer	Businesswire
03-Oct-2023	Enveric Biosciences Announces its Psybrary™ Portfolio Now Totals Over 1000 Psychedelic-Inspired Therapeutic Candidates	Businesswire
03-Oct-2023	Meitheal Pharmaceuticals Announces Expansion of Portfolio of Generic Injectable Products	Businesswire
03-Oct-2023	Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 25, 2023	Businesswire
03-Oct-2023	Fresenius Kabi Named 2023 Supplier Partner of the Year by Vizient	Businesswire
03-Oct-2023	Equillium to Host Analyst & Investor Day	Businesswire
03-Oct-2023	PharmaEssentia Enters Into Exclusive Global License Agreement With WuXi Biologics for a Myeloid Immune Checkpoint Antibody Candidate	Businesswire
03-Oct-2023	IQVIA Builds on its Strategic Collaboration with argenx to Provide Safety Systems and Services	Businesswire
03-Oct-2023	RoslinCT Boston Appoints Dean J. Morris, as Chief Operations Officer	Businesswire
03-Oct-2023	Massive Bio Pioneers Clinical Trial Recruitment Innovation with Strategic Support from Evernorth Health, Inc.	Businesswire
03-Oct-2023	Rallybio to Present at the JonesTrading 2023 Healthcare Summit	Businesswire
03-Oct-2023	Iambic Therapeutics Announces Close of Oversubscribed $100 Million Series B Financing to Advance AI-Discovered Therapeutics into Clinical Development and Enters Collaboration with NVIDIA	Businesswire
03-Oct-2023	Immunome and Morphimmune Announce Successful Completion of Merger with $125 Million PIPE to Develop Novel Targeted Cancer Therapies	Businesswire
03-Oct-2023	Atomwise Announces Nomination of its First AI-Driven Development Candidate Focused on TYK2 Inhibition and Appoints Neely Mozaffarian, MD, PhD as Chief Medical Officer	Businesswire
03-Oct-2023	Bellen Chemistry Further Validates its R&D Facilities by Participating in VERIF.i®, Scientist.com’s Supplier Pre-assessment Program	Businesswire
03-Oct-2023	Lokavant Announces $8M Strategic Investment from Mitsui & Co. to Expand AI and Predictive Clinical Trial Intelligence into Asia-Pacific	Businesswire
03-Oct-2023	Wiliot Named Best ‘Innovation in Fulfilment/Supply’ at Inaugural European Vendors in Partnership Awards	Businesswire
03-Oct-2023	Promega to Develop Microsatellite Instability (MSI) Companion Diagnostic IVD Kit in Collaboration With GSK	Businesswire